Literature DB >> 22428586

Mapping microclimate pH distribution inside protein-encapsulated PLGA microspheres using confocal laser scanning microscopy.

Yajun Liu1, Steven P Schwendeman.   

Abstract

The pH in the aqueous pores of poly(lactide-co-glycolide) (PLGA) matrix, also referred to as microclimate pH (μpH), is often uncontrolled, ranging from highly acidic to neutral pH range. The μpH distribution inside protein-encapsulated PLGA microspheres was quantitatively evaluated using confocal laser scanning microscopy. The fluorescent response of Lysosensor yellow/blue dextran used to map μpH in PLGA was influenced by the presence of encapsulated protein. The nonprotonated form of pyridyl group on the fluorescence probe at neutral pH was responsible for the interference, which was dependent on the type and concentration of protein. A method for correction of this interference based on estimating protein concentration inside the microspheres was established and validated. After correction of the influence, the μpH distribution kinetics inside microspheres was evaluated for different PLGA 50/50 microsphere formulations under physiological conditions for 4 weeks. Generally, the μpH acidity increased with the progression of incubation time. The coincorporation of poorly soluble base, magnesium carbonate, in the microspheres prolonged the appearance of detectable acidity for up to 3 weeks. Co-addition of an acetate buffer was able to control the μpH over a slightly acidic range (around pH 4.7) after two week incubation. Microspheres prepared from a lower polymer concentration exhibited a higher μpH, likely owing to reduced diffusional resistance to acidic degradation products. The stability of protein was enhanced by addition of MgCO(3), acetate buffer, or by reduced polymer concentration in the preparation, as evidenced by more soluble protein recovered after incubation. Hence, the μpH imaging technique developed can be employed in the future for optimization of formulation strategies for controlling μpH and stabilizing encapsulated proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428586      PMCID: PMC3817562          DOI: 10.1021/mp200608y

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  22 in total

1.  pH and osmotic pressure inside biodegradable microspheres during erosion.

Authors:  A Brunner; K Mäder; A Göpferich
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 2.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

3.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.

Authors:  Y Y Yang; T S Chung; N P Ng
Journal:  Biomaterials       Date:  2001-02       Impact factor: 12.479

4.  Mapping neutral microclimate pH in PLGA microspheres.

Authors:  Lei Li; Steven P Schwendeman
Journal:  J Control Release       Date:  2005-01-03       Impact factor: 9.776

5.  Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.

Authors:  Amy G Ding; Anna Shenderova; Steven P Schwendeman
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

6.  Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives.

Authors:  G Zhu; S P Schwendeman
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 7.  Serum albumin.

Authors:  T Peters
Journal:  Adv Protein Chem       Date:  1985

Review 8.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

Authors:  Wenlei Jiang; Rajesh K Gupta; Mangesh C Deshpande; Steven P Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2005-01-10       Impact factor: 15.470

9.  Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.

Authors:  K Fu; D W Pack; A M Klibanov; R Langer
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

10.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres.

Authors:  Wenlei Jiang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2008-08-19       Impact factor: 4.939

View more
  9 in total

1.  Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres.

Authors:  Feng Qi; Jie Wu; Dongxia Hao; Tingyuan Yang; Yu Ren; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2014-01-08       Impact factor: 4.200

Review 2.  Injectable controlled release depots for large molecules.

Authors:  Steven P Schwendeman; Ronak B Shah; Brittany A Bailey; Anna S Schwendeman
Journal:  J Control Release       Date:  2014-06-12       Impact factor: 9.776

3.  Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.

Authors:  Feng Qi; Liuqing Yang; Jie Wu; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

4.  Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.

Authors:  Jiwei Liu; Yan Xu; Yonglu Wang; Hao Ren; Zhengjie Meng; Kuntang Liu; Zhe Liu; He Huang; Xueming Li
Journal:  Pharm Res       Date:  2019-06-04       Impact factor: 4.200

5.  Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.

Authors:  Stephen C Balmert; Andrew C Zmolek; Andrew J Glowacki; Timothy D Knab; Sam N Rothstein; Joseph M Wokpetah; Morgan V Fedorchak; Steven R Little
Journal:  J Mater Chem B       Date:  2015-06-21       Impact factor: 6.331

6.  Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.

Authors:  Kevin L Schully; Sadhana Sharma; Kevin J Peine; John Pesce; Margret A Elberson; Mariko E Fonseca; Angela M Prouty; Matthew G Bell; Hassan Borteh; Matthew Gallovic; Eric M Bachelder; Andrea Keane-Myers; Kristy M Ainslie
Journal:  Pharm Res       Date:  2013-01-25       Impact factor: 4.200

7.  Characterization of nanostructured ureteral stent with gradient degradation in a porcine model.

Authors:  Xiaoqing Wang; Hongli Shan; Jixue Wang; Yuchuan Hou; Jianxun Ding; Qihui Chen; Jingjing Guan; Chunxi Wang; Xuesi Chen
Journal:  Int J Nanomedicine       Date:  2015-04-20

8.  Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.

Authors:  Malgosia M Pakulska; Irja Elliott Donaghue; Jaclyn M Obermeyer; Anup Tuladhar; Christopher K McLaughlin; Tyler N Shendruk; Molly S Shoichet
Journal:  Sci Adv       Date:  2016-05-27       Impact factor: 14.136

9.  Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study.

Authors:  Max Beugeling; Katie Amssoms; Freek Cox; Ben De Clerck; Ellen Van Gulck; Jeroen A Verwoerd; Guenter Kraus; Dirk Roymans; Lieven Baert; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Pharmaceutics       Date:  2019-10-03       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.